About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval...

25
About OMICS Group OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 500 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS Group also organizes 500 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Transcript of About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval...

Page 1: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

About OMICS Group

OMICS Group is an amalgamation of Open Access Publications and

worldwide international science conferences and events. Established in the

year 2007 with the sole aim of making the information on Sciences and

technology ‘Open Access’, OMICS Group publishes 500 online open access

scholarly journals in all aspects of Science, Engineering, Management and

Technology journals. OMICS Group has been instrumental in taking the

knowledge on Science & technology to the doorsteps of ordinary men and

women. Research Scholars, Students, Libraries, Educational Institutions,

Research centers and the industry are main stakeholders that benefitted

greatly from this knowledge dissemination. OMICS Group also organizes 500

International conferences annually across the globe, where knowledge

transfer takes place through debates, round table discussions, poster

presentations, workshops, symposia and exhibitions.

Page 2: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

OMICS International Conferences

OMICS International is a pioneer and leading science event organizer,

which publishes around 500 open access journals and conducts over 500

Medical, Clinical, Engineering, Life Sciences, Pharma scientific conferences

all over the globe annually with the support of more than 1000 scientific

associations and 30,000 editorial board members and 3.5 million followers

to its credit.

OMICS Group has organized 500 conferences, workshops and national

symposiums across the major cities including San Francisco, Las Vegas,

San Antonio, Omaha, Orlando, Raleigh, Santa Clara, Chicago,

Philadelphia, Baltimore, United Kingdom, Valencia, Dubai, Beijing,

Hyderabad, Bengaluru and Mumbai.

Page 3: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Application of Systems Thinking and

Systems Engineering Principles to

Enhance Safety and Pharmacovigilance

through Real-Time Informatics

Greg Koski, PhD, MD

President and CEO

Alliance for Clinical Research Excellence and Safety

Page 4: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Drug Development Today—

A Complex Ecosystem under

Intense Environmental Pressure

In a rapidly

changing

environment

the ability to

survive is

determined

by the ability

to adapt!

Page 5: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

“The drug development model has not fundamentally

changed in more than 50 years, when the Kefauver-

Harris Amendments of 1962 established the current

standard for the clinical testing of investigational

drugs”….

--Kenneth I. Kaitin, PhD

Tufts CSDD Director

Page 6: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Change Management—

It takes a crisis!

“The current approach to drug

development is inefficient,

ineffective and unsustainable.”

DIA Europe, 2010

Page 7: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

From Silos to Network Systems

Page 8: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Fundamental Elements of an Enterprise

System for Clinical Research

Global Network of Accredited Sites and

Professionally Certified Clinical Research Workforce

Standardized Policies and Operational

Procedures

Integrated Supply Chain Logistics

Shared Information Infrastructure

Quality Risk Management System

Connectivity

Interoperability

High-Reliability

Quality & Safety

Page 9: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Systems Thinking: The Global Air Transport System

Page 10: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Service

Providers

Sponsors

Regulators

Government

Agencies

Ethics

Committees

Patients

and

Healthcare

Systems

Inputs

Test Articles

Protocols

Contracts

Regulations

Boundaries

Logistics

Finances

Technologies

Collaborations

Patents

Outputs

Data

Safety

Quality

Efficiency

Approval

Market Share

Profitability

Sustainability

Respectability

Better Health

Quality of Life

Productivity

Development

People

R&D Team

Operations Team

Investigators

Coordinators

Monitors

Auditors

Technologists

Data Managers

Ethicists

Regulators

Patients/Families

Physicians

Administrators

CROs and

SMOs

Optimize

Clinical Trial

Performance

Research

Sites

and

Networks

Processes Development

Pre-Clinical

Protocol Development

Regulatory Approval

EC Approval

Site Selection

Study Start-up

Trial Conduct

Data Collection

Data Analysis

Quality Management

Adverse Events

Reporting

Monitoring

Auditing

NDA

Approval

Marketing

Advertising

Manufacturing

Distribution

Page 11: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Service

Providers

Sponsors

Regulators

Government

Agencies

Ethics

Committees

Patients

and

Healthcare

Systems

Inputs

Test Articles

Protocols

Contracts

Regulations

Boundaries

Logistics

Finances

Technologies

Collaborations

Patents

People

R&D Team

Operations Team

Investigators

Coordinators

Monitors

Auditors

Technologists

Data Managers

Ethicists

Regulators

Patients/Families

Physicians

Administrators

Processes

Development

Pre-Clinical

Protocol Development

Regulatory Approval

EC Approval

Site Selection

Study Start-up

Trial Conduct

Data Collection

Data Analysis

Quality Management

Adverse Events

Reporting

Monitoring

Auditing

NDA

Approval

Marketing

Advertising

Manufacturing

Distribution

CROs and

SMOs

Systems-Focused

Clinical Research

Enterprise

Research

Sites

and

Networks

Outputs

Data

Safety

Quality

Efficiency

Approval

Market Share

Profitability

Sustainability

Respectability

Better Health

Quality of Life

Productivity

Development

Page 12: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Service

Providers

Sponsors

Regulators

Government

Agencies

Ethics

Committees

Patients

and

Healthcare

Systems

Inputs

Test Articles

Protocols

Contracts

Regulations

Boundaries

Logistics

Finances

Technologies

Collaborations

Patents

People

R&D Team

Operations Team

Investigators

Coordinators

Monitors

Auditors

Technologists

Data Managers

Ethicists

Regulators

Patients/Families

Physicians

Administrators

CROs and

SMOs

Research

Sites

and

Networks

Processes

Development

Pre-Clinical

Protocol Development

Regulatory Approval

EC Approval

Site Selection

Study Start-up

Trial Conduct

Data Collection

Data Analysis

Quality Management

Adverse Events

Reporting

Monitoring

Auditing

NDA

Approval

Marketing

Advertising

Manufacturing

Distribution

Outputs

Data

Safety

Quality

Efficiency

Approval

Market Share

Profitability

Sustainability

Respectability

Better Health

Quality of Life

Productivity

Development

Page 13: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

A non-profit multi-sector alliance of like-minded people and organizations working collaboratively in the public interest to build a shared global system for clinical research excellence—

To promote Accountable ResearchTM by aligning ethical principles and profesionalism with good business, scientific, medical and regulatory practices, within an enterprise safety culture.

What is ACRES?

Page 14: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Initial projects are underway in each of four operational domains where critical processes for research sites, sponsors, CROs, regulatory authorities, ethics committees, and research subjects intersect to achieve "clean data” with greater efficiency, safety and interoperability -- at the points where change is most needed.

ACRES Foundation Initiatives

Executive Office

Page 15: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

“For too long, the industry has failed to recognize the importance and value of well-established, sustainable, high-performing research sites. They are a resource that we have undervalued. Now is the time for us to take a more systemic approach that promotes site productivity and sustainability…”

--Briggs Morrison, MD

Vice-President for Global Medicines Development

and Chief Medical Officer, AstraZeneca

Member of the ACRES Board of Directors

Sites Matter!

Page 16: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

The Harsh Reality of Clinical

Research Sites Today

• 70% of clinical research sites never do more than one clinical

trial in the business lifetime

• Fewer than half of sites meet enrollment goals and 10% never

enroll a single subject

• Few sites have professionally trained and certified research

personnel

• Many sites are still using paper records without EDC/CTMS

• Monitoring accounts for nearly one-third on clinical trial

budgets

• Redundancy, delays, non-compliance, and poor quality are the

norm rather than the exception

Page 17: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Elements of Effective

Accreditation

Appropriate

Standards

• Must be meaningful

• Measurable metrics

• Multi-stakeholder

Effective

Processes

• Minimize burdens

• Maximize value

• Neutral third-party

Independent Oversight

• Ensure integrity

• Evaluate effectiveness

Global Accreditation

“Recognition

of

Excellence”

Page 18: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Establish an efficient, effective and representative Project Steering Committee

Engage critical stakeholders to champion efforts for site accreditation and workforce certification

Convene broad-based Collaboration Summit (s) to refine Scope, Strategy and Structure

Empower a Global Working Group for Standards and Process Development

Develop and Implement necessary standards and agreements

Pilot Test and feedback from stakeholders

Refine standards and implementation through regional networks

Evolving needs of Society and

Stakeholders

• Public Trust • Professionalism

• Quality Assurance • Site Performance • Risk Management

• Information Technology

Sustainable system infrastructure to drive clinical

research quality, safety and efficiency

2013

2014

2015

2016

Site Accreditation Standards Initiative

Page 19: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

ACRES Value Proposition

Urgent Challenges

–Education and training

–Trial complexity

–Site selection

–Performance

–Monitoring

–Data management

–Pharmacovigilance

–Regulatory compliance

–Delays and redundancy

–Time to market

–Ethical review

–Misconduct

–Public confidence

–Economic pressures

–Global disparities

More effective application of existing resources to build a sustainable, shared “system infrastructure” will provide a handsome return on investment-- economically, scientifically and socially.

Current estimates of waste due to inefficiency

and redundancy in the clinical trials process is

approximately 30%

An effective system could realize annual savings in

excess of $20 Billion

Page 20: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Implementation Strategy and Timeline

Maturation and Consolidation

New Standards and Metrics; New strategic alliances; Performance Excellence; Self-sustaining organization

Establishment and Growth of the Network

Site identification; education and training ; regional expansion; products and services delivery; ”modular

growth” opportunities by adding existing networks

Engaging Alliance Partners and Stakeholders

Standards, Metrics, Processes; Guidelines; IT Integration; Education, Certification and Accreditation

Criteria; Quality Assurance

Phase 1 2012

Phase 2 2015

Phase 3 2017

Page 21: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Safety and

Pharmacovigilance—

Why are we flying blind?

Personal Health and Biological Information (including Genomics)

Clinical Trials and Trial-Generated Adverse Reaction Data

Monitoring and Oversight Data

Page 22: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

The Power of Data Standards,

Sharing and Aggregation

Aggregation

&

Analytics

EHR/

Biological

EDC/

CTMS

Monitoring/ Audit Standards

Page 23: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Global

Dynamic

Accreditation

Process

Quality

Enterprise

Management

Smart

Monitoring

Smart

Auditing

Site Director

Study

Coordinator(s)

Operations Manager(s)

Data Manager(s)

Investigator(s)

Informatics Specialist(s)

Study Sites

Personnel

Facilities

Administration

Information Technology

Quality Management

Research Integrity

Patient Engagement

Personnel

Facilities

Administration and Finance

Information Technology

Quality Management

Nurses and Technicians

Standards

Global Site Network

Information

Systems

CTMS

Risk

Monitors

Operations

Dashboard

Compliance

Monitor

Enrollment

Manager

EDC

Enrollment

Manager

Healthcare

Organizations

Supply Chain

Providers

Industry Sponsors Pharmaceuticals

Biotechnology

Medical Devices

Regulatory

Oversight

Agencies

Universal Collaborative Interface Cloud-Based Enterprise Data Vault

Secure Data Aggregation and Interchange

API Integrated Technology Applications

Intelligent Analytic Engines

Federated Trust Framework Identity Management

Secure Digital Transactions

eCommerce

Clinical

Data

Operational

Data

Safety

Data

Financial

Data

Metadata

Library Data

Services

Electronic Health Data

Patient Demographics

Contract Research

Organizations

Ethics Review

Boards

Real-Time

Pharmaco-

vigilance

Smart

Financial

Engine

Site Management

Organizations

Integrated Logistics

All rights reserved, Alliance for Clinical Research Excellence and Safety, 2015

Page 24: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Committed to Systems Solutions

for Accountable ResearchTM

Page 25: About OMICS Group · Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up ... •Must be meaningful •Measurable metrics •Multi-stakeholder

Let us meet again..

We welcome you all to our future conferences of OMICS International

5th International Conference & Exhibition on Pharmacovigilance & Clinical Trials

On

September 19 - 21, 2016 at Vienna, Austria http://pharmacovigilance.pharmaceuticalconferences.com/